Skip to main content

DarioHealth Corp.

DRIO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001533998

In the last 90 days, DarioHealth Corp. insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $9.69M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by DarioHealth Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $100.0K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$100.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for DarioHealth Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for DarioHealth Corp.
NameTitleLast reported holdingLast filingFilings, past year
Matheis DennisDirector43,026Jul 28, 20261
McGrath Dennis MDirector27,737Sep 15, 20250
Stern Adam KDirector29,717Sep 15, 20250
Leisure Lawrence B.Director20,000Sep 15, 20250
Raphael ErezChief Executive Officer156,853Sep 15, 20250
Karah HilaDirector30,965Sep 15, 20250
Shaked YoavDirector32,810Sep 15, 20250
Franco-Yehuda ChenChief Financial Officer30,000Sep 15, 20250
Nelson Steven CharlesPresident and CCO34,750Sep 15, 20250
Kaplan Jon H.Director111,574Feb 25, 20250
Anderson Richard AllanPresident108,877Mar 8, 20240
Ben-David ZviChief Financial Officer746,035Mar 8, 20240
Ben-Kiki TomerChief Operating Officer–Feb 21, 20240
Stone Richard BDirector–May 20, 20220
Bacher DrorChief Operating Officer265,926May 20, 20220
Cohen OdedGM MSK430,764Oct 15, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 28, 2026 (view filing)5:27 PM ETJul 235 daysLateMatheis DennisDirectorPPurchase+14.4K$6.93+$100.0K+50.5%43.0K after
Aug 27, 2025 (view filing)Aug 27Same dayNelson Steven CharlesPresident and CCOPPurchase+40.0K$0.53+$21.2K+72.7%95.0K after
Jan 10, 2025 (view filing)Jan 73 daysStern Adam KDirectorPPurchaseSeries D-2 Preferred Stock+100$1,000.00+$100.0K–0 afterDerivative
Nov 14, 2024 (view filing)Nov 122 daysNelson Steven CharlesChief Commercial OfficerPPurchase+5.00K$0.91+$4.55K+10.0%55.0K after
Sep 12, 2024 (view filing)Sep 10-112 daysNelson Steven CharlesChief Commercial OfficerPPurchase+10.0K$0.82+$8.20K+25.0%50.0K after2 lots
Sep 10, 2024 (view filing)Sep 5-95 daysLateNelson Steven CharlesChief Commercial OfficerPPurchase+15.0K$0.82+$12.3K+60.0%40.0K after3 lots
Aug 28, 2024 (view filing)Aug 271 dayRaphael ErezChief Executive OfficerPPurchase+5.00K$0.88+$4.40K+0.3%1.94M after
Aug 23, 2024 (view filing)Aug 21-232 daysNelson Steven CharlesChief Commercial OfficerPPurchase+15.0K$0.9433+$14.2K+150.0%25.0K after3 lots
Aug 23, 2024 (view filing)Aug 20-213 daysLateRaphael ErezChief Executive OfficerPPurchase+10.0K$0.94+$9.40K+0.5%1.93M after2 lots
Aug 20, 2024 (view filing)Aug 19-201 dayNelson Steven CharlesChief Commercial OfficerPPurchase+10.0K$0.93+$9.30KNew position10.0K after2 lots
Aug 20, 2024 (view filing)Aug 16-194 daysRaphael ErezChief Executive OfficerPPurchase+10.0K$0.898+$8.98K+0.5%1.92M after3 lots
May 8, 2023 (view filing)May 44 daysMatheis DennisDirectorPPurchaseSeries B-2 Preferred Stock+50$1,000.00+$50.0K–50 afterDerivative
May 8, 2023 (view filing)May 44 daysShaked YoavDirectorPPurchaseSeries B-2 Preferred Stock+40$1,000.00+$40.0K–40 afterDerivative
May 8, 2023 (view filing)May 44 daysKaplan Jon H.DirectorPPurchaseSeries B-2 Preferred Stock+30$1,000.00+$30.0K–30 afterDerivative
May 8, 2023 (view filing)May 44 daysRaphael ErezChief Executive OfficerPPurchaseSeries B-2 Preferred Stock+30$1,000.00+$30.0K–30 afterDerivative
Jan 18, 2023 (view filing)Jan 135 daysRaphael ErezChief Executive OfficerSSale−1.20K$6.21−$7.45K−0.1%1.11M after
Dec 23, 2022 (view filing)Dec 212 daysMcGrath Dennis MDirectorSSale−9.87K$3.97−$39.2K−11.7%74.7K after
Nov 10, 2021 (view filing)Nov 82 daysBacher DrorChief Operating OfficerSSale−804$19.09−$15.3K−0.5%170.9K after
Nov 9, 2021 (view filing)Nov 5-84 daysRaphael ErezChief Executive OfficerSSale−1.00K$19.07−$19.1K−0.1%838.3K after2 lots
Nov 8, 2021 (view filing)Nov 4-54 daysBacher DrorChief Operating OfficerSSale−400$19.07−$7.63K−0.2%171.7K after2 lots
Nov 5, 2021 (view filing)Nov 3-42 daysRaphael ErezChief Executive OfficerSSale−38.3K$18.86−$723.2K−4.4%839.3K after2 lots
Nov 4, 2021 (view filing)Nov 2-32 daysBacher DrorChief Operating OfficerSSale−12.4K$19.11−$236.5K−6.7%172.1K after2 lots
Nov 3, 2021 (view filing)Nov 1-22 daysRaphael ErezChief Executive OfficerSSale−67.1K$18.41−$1.23M−7.1%877.6K after2 lots
Oct 15, 2021 (view filing)Oct 141 dayCohen OdedGM MSKSSale−20.0K$16.11−$322.2K−4.4%430.8K after
Jul 19, 2021 (view filing)Jul 154 daysRaphael ErezChief Executive OfficerSSale−1.30K$17.63−$22.9K−0.1%943.3K after
Jul 7, 2021 (view filing)Jul 2-65 daysBacher DrorChief Operating OfficerSSale−13.5K$20.57−$277.7K−6.8%183.8K after2 lots